Diabetic Retinopathy Market is Expected to Reach US$ 13.0 Billion by 2032 IMARC Group has recently released a new research study titled “Diabetic Retinopathy Market Report by Type (Proliferative Diabetic Retinopathy, Non-proliferative Retinopathy), Treatment Type (Anti VEGF Drugs, Steroid Implants, Laser Surgeries, Vitrectomy), End-User (Hospitals and Pharmacies, Eye Clinics, Ambulatory Surgical Centres (ASCs), and Others), and Region 2024-2032”, offers a...
0 Поделились
21 Просмотры
0 предпросмотр